Read previous post:
tso3
Byron Capital’s Loe says TS03 Faces Delays, but is Worth the Wait

Yesterday, TSO3 (TSX:TOS) announced that the US Regulatory Agency requested more information about its ozone-based hospital sterilization platform Optreoz. Ric...

Close